Tokyo, Japan - January 26, 2022 - MBL has received approval on January 14, 2022 to manufacture and market the MEBGENTM AZF Deletion Kit, an IVD product that determines the presence or absence of microdeletions on the Y chromosome based on the PCR-rSSO (polymerase chain reaction-reverse sequence specific oligonucleotide) method.

The kit is designed to detect the presence or absence of AZF (Azoospermia Factor) deletion and the type of AZF deletion in Japanese men prior to microdissection testicular sperm extraction (micro-TESE) for male infertility. It is useful for the Y-chromosome microdeletion test.